- Report
- January 2024
- 190 Pages
Latin America
From €5344EUR$5,950USD£4,577GBP
- Report
- May 2024
- 182 Pages
Global
From €3435EUR$3,825USD£2,942GBP
€4041EUR$4,500USD£3,461GBP
- Report
- August 2023
- 112 Pages
Global
From €3435EUR$3,825USD£2,942GBP
€4041EUR$4,500USD£3,461GBP
- Report
- January 2022
- 115 Pages
Global
From €4266EUR$4,750USD£3,654GBP
- Report
- February 2023
- 199 Pages
Europe
From €3098EUR$3,450USD£2,654GBP
- Report
- June 2022
- 182 Pages
Global
From €3996EUR$4,450USD£3,423GBP
- Report
- September 2022
- 132 Pages
Europe
From €3098EUR$3,450USD£2,654GBP
- Report
- July 2019
- 72 Pages
Global
From €2919EUR$3,250USD£2,500GBP
- Report
- May 2019
- 83 Pages
Global
From €2919EUR$3,250USD£2,500GBP
- Report
- November 2023
- 122 Pages
Global
From €3500EUR$4,175USD£3,103GBP
- Report
- April 2025
- 90 Pages
Global
From €3500EUR$4,175USD£3,103GBP
- Report
- January 2025
- 132 Pages
Global
From €853EUR$950USD£731GBP

The Wound Care Biologics market is a subset of the larger Wound Care industry. It focuses on the use of biologic products to treat wounds, such as skin grafts, tissue adhesives, and other biologic dressings. These products are designed to promote healing and reduce the risk of infection. They are often used in combination with traditional wound care treatments, such as dressings and topical medications.
The Wound Care Biologics market is driven by the increasing prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers. The rising demand for advanced wound care products, such as biologic dressings, is also driving the market.
Some of the major companies in the Wound Care Biologics market include Smith & Nephew, ConvaTec, Mölnlycke Health Care, Integra LifeSciences, and Acelity. Show Less Read more